<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894320</url>
  </required_header>
  <id_info>
    <org_study_id>JBL_2014-28</org_study_id>
    <nct_id>NCT02894320</nct_id>
  </id_info>
  <brief_title>The Impact of Parkinson's Disease on Internal Preactivation of Sensory Effects of Intention-based Actions. A Subliminal Priming Study</brief_title>
  <acronym>DYNIDEO</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      The ability to predict sensory effects of people's own motor actions is a key component of
      Human action realization. Recent studies revealed this anticipation process to be involved in
      early and late stages of voluntary actions. Nevertheless, the question whether the
      action-effect anticipation is impacted or not by &quot;motor pathologies&quot;, such as the Parkinson's
      disease, remains unclear. The current study is aimed to clarify this issue by using a
      subliminal priming paradigm in patients with Parkinson's disease and in matched control
      participants. Indeed, subliminal primes corresponding to visual action-effects are displayed
      at different time points before the actions' execution. Results should allow to determine
      whether or not the action-effect prediction is impaired at different stages of voluntary
      action in patients with Parkinson's disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reaction time</measure>
    <time_frame>baseline</time_frame>
    <description>time measured in seconds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>error rate</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">28</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Parkinson's disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>gender and age matched with Parkinson's disease patients, whose data will be extracted from an existing database</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral observation</intervention_name>
    <arm_group_label>Parkinson's disease</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Parkinson's disease, according to the MDS-UPDRS III (Movement Disorder
        Society-sponsored revision of the Unified Parkinson's Disease Rating Scale), matched for
        gender and for age with healthy subjects from a database.

        This database has already been constituted by the CNRS (Centre national de la recherche
        scientifique, Laboratory of Psychology of Perception - UMR8242).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults age 18 years and older

          -  Parkinson's disease

        Exclusion Criteria:

          -  Other pathology or neurological or psychiatric history

          -  Known pregnancy or breastfeeding

          -  Absence of affiliation to social security or universal health coverage (CMU)

          -  Person under legal protection

          -  Patient's opposition to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2016</study_first_submitted>
  <study_first_submitted_qc>September 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Voluntary action</keyword>
  <keyword>Action-effect preactivation</keyword>
  <keyword>Action-effect prediction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

